Patrickg Lepore News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrickg lepore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrickg Lepore Today - Breaking & Trending Today

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Expands By 1,157.1%

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 88,000 shares, a growth of 1,157.1% from the December 15th total of 7,000 shares. Based on an average trading volume of 401,800 shares, the short-interest ratio […] ....

Patrickg Lepore , Susquehanna International Group , Vyne Therapeutics Inc , Mackenzie Financial Corp , Beacon Pointe Advisors , Therapeutics Inc , Securities Exchange Commission , Cetera Advisor Networks , Get Free Report , Director Patrick , Exchange Commission , Financial Corp , Advisor Networks , Pointe Advisors , International Group , Trading Down , Vyne Therapeutics , Nasdaq Vyne ,

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Decreases By 94.4%

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Free Report) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 7,000 shares, a drop of 94.4% from the November 30th total of 124,800 shares. Based on an average daily volume of 366,400 shares, the days-to-cover ratio […] ....

Patrickg Lepore , Therapeutics Company Profile , Millennium Management , Securities Exchange Commission , Vyne Therapeutics Inc , Renaissance Technologies , Mackenzie Financial Corp , Beacon Pointe Advisors , Cetera Advisor Networks , Therapeutics Inc , Get Free Report , Director Patrick , Exchange Commission , Advisor Networks , Pointe Advisors , Vyne Therapeutics , Nasdaq Vyne ,

VYNE Therapeutics Inc. (NASDAQ:VYNE) Sees Large Decline in Short Interest

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 91,900 shares, a decline of 55.6% from the April 30th total of 206,800 shares. Currently, 2.9% of the shares of the company are sold short. Based on […] ....

Patrickg Lepore , Cantor Fitzgerald , Vyne Therapeutics Inc , Beacon Pointe Advisors , Susquehanna International Group , Therapeutics Company Profile , Millennium Management , Cetera Advisor Networks , Molecule Stabilizing Technology , Therapeutics Inc , Get Rating , Director Patrick , International Group , Advisor Networks , Molecule Stabilizing , Vyne Therapeutics , Nasdaq Vyne ,

VYNE Therapeutics (NASDAQ:VYNE) Price Target Increased to $9.00 by Analysts at Cantor Fitzgerald

VYNE Therapeutics (NASDAQ:VYNE – Get Rating) had its price target lifted by Cantor Fitzgerald from $5.00 to $9.00 in a report released on Friday morning, The Fly reports. Separately, HC Wainwright reaffirmed a buy rating and set a $28.00 target price on shares of VYNE Therapeutics in a report on Wednesday, April 19th. VYNE Therapeutics […] ....

Patrickg Lepore , Molecule Stabilizing Technology , Beacon Pointe Advisors , Mackenzie Financial Corp , Cetera Advisor Networks , Therapeutics Inc , Millennium Management , Cantor Fitzgerald , Therapeutics Company Profile , Get Rating , Director Patrick , Financial Corp , Advisor Networks , Pointe Advisors , Molecule Stabilizing , Vyne Therapeutics , Nasdaq Vyne , Boost Price Target ,

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Increases By 119.1%

VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 206,800 shares, an increase of 119.1% from the April 15th total of 94,400 shares. Based on an average daily volume of 694,700 shares, the days-to-cover ratio is […] ....

Patrickg Lepore , Securities Exchange Commission , Cetera Advisor Networks , Renaissance Technologies , Therapeutics Company Profile , Therapeutics Inc , Beacon Pointe Advisors , Molecule Stabilizing Technology , Millennium Management , Mackenzie Financial Corp , Vyne Therapeutics Inc , Get Rating , Director Patrick , Exchange Commission , Financial Corp , Advisor Networks , Pointe Advisors , Molecule Stabilizing , Vyne Therapeutics , Nasdaq Vyne ,